Právní předpis byl sestaven k datu 12.05.2009.
Zobrazené znění právního předpisu je účinné od 13.05.2009 do 12.05.2009.
114
VYHLÁŠKA
xx dne 17. xxxxx 2009,
xxxxxx xx xxxx xxxxxxxx x. 384/2007 Xx., x xxxxxxx xxxxxxxxxxxx xxxxxx
Ministerstvo xxxxxxxxxxxxx stanoví podle §39c xxxx. 1 xxxxxx č. 48/1997 Xx., x veřejném xxxxxxxxxx xxxxxxxxx x x xxxxx a xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxx č. 261/2007 Xx.:
Xx. X
Xxxxxxx x vyhlášce č. 384/2007 Sb., o xxxxxxx xxxxxxxxxxxx skupin, zní:
"Xxxxxxx x vyhlášce x. 384/2007 Xx.
Xxxxxx xxxxxxxxxxxx skupin
xxxxx xxxx- xxxxxxxx xxxxxxx | xxxxxxxxxxxx xxxxxxx | xxxxx xxxxxxxxxx xxxxxxx | xxxxxxxxxx skupina*) | xxxxxx xxxxx x xxxxxxxxxx xxxxxxx xxxxxxxxxxx |
1 | Xxxxxx k xxxxxxx xxxxxxxxxxxxxxxx vředové xxxxxxx x xxxxxxxx xxxxxxx xxxxx | 1/2 | xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx a xxxxxxxx choroby jícnu, xxxxxxxxxxx X2 receptorů, xxxxxx. | X02XX01 cimetidin, X02XX02 xxxxxxxxx, X02XX03 xxxxxxxxx |
1/3 | léčiva k xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxxx xxxxx, x.x. | X02XX01 omeprazol, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxx, X02XX05 xxxxxxxxxxx | ||
1/4 | xxxxxx x terapii gastroduodenální xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxxx pumpy, xxxxxx. | X02XX01 xxxxxxxxx, X02XX02 pantoprazol, X02XX05 xxxxxxxxxxx | ||
2 | Xxxxxxxxxxxx | 2/1 | spasmolytika, x.x. | X03XX04 xxxxxxxxx, A03AB06 xxxxxxxxx bromid, X03XX02 xxxxxxxxxx, X03XX01 xxxxxxxxxxxxxxx |
2/2 | xxxxxxxxxxxx, parent. | X03XX01 xxxxxxxxx, X03XX02 drotaverin | ||
3 | Xxxxxxxxxxx | 3/1 | xxxxxxxxxxx, p.o. | X03XX01 xxxxxxxxxxxxx, X03XX03 xxxxxxxxxx, X03XX itoprid |
4 | Xxxxxxxxxxx | 4/1 | xxxxxxxxxxx, xxxxxxx, x.x. | X04XX01 xxxxxxxxxxx, X04XX02 granisetron |
4/2 | xxxxxxxxxxx, setrony, parent. x xxxx. xxxxxxxx | X04XX01 xxxxxxxxxxx, A04AA02 xxxxxxxxxxx, X04XX05 palonosetron | ||
4/3 | xxxxxxxxxxx, xxxxxxx, p.o | X06XX03 xxxxxxxxxxxxxxx, X04XX xxxxxxxx | ||
5 | Xxxxxx x terapii zánětlivých xxxxxxxxx onemocnění | 5/1 | xxxxxx x terapii xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxxxxxx xxxxxxxxxxxxxxxx x xx látky podobné, x.x. | A07EC01 xxxxxxxxxxxx, X07XX02 mesalazin |
6 | Xxxxxxxxxxxxx mikroorganismy | 6/1 | xxxxxxxxxxxxx xxxxxxxxxxxxxx, x.x. | X07XX xxxxxxxxxxxxx xxxxxxxxxxxxxx - Xxxxxxxxxxx coli, X07XX01 organismy xxxxxxxxxxx xxxxxxxx mléčnou, X07XX02 Xxxxxxxxxxxxx xxxxxxxx xxxxxxx |
7 | Xxxxxxxxxxxxx xxxxxxxxx | 7/1 | xxxxxxxxxxxxx přípravky, xxxxxxxxxxxxx lékové xxxxx, x.x. | A09AA02 xxxxxxxxxxxxx xxxxxxxxx - mikronizované xxxxxx formy xxx 20&xxxx;000 U x xxxxx xxxxxxx |
8 | Xxxxxx k terapii xxxxxxx - xxxxxxxx | 8/1 | xxxxxx x xxxxxxx diabetu, xxxxxxx xxxxxx - lahvičky, xxxxx. | X10XX01 xxxxxxx xxxxxx xxxxxx působící, X10XX01 xxxxxxx xxxxxx xxxxxxx xxxxxx xxxxxxxx |
8/2 | xxxxxx x xxxxxxx xxxxxxx, xxxxxxx xxxxxx - xxxxxxxxx, xxxxxxx xxxxxxxx - xxxxxxxx x xxxxxxxxx, xxxxxx. | X10XX01 insulin lidský, X10XX04 xxxxxxx xxxxxx, X10XX05 xxxxxxx xxxxxx, X10XX06 xxxxxxx xxxxxxxx, X10XX01 xxxxxxx lidský, X10XX01 xxxxxxx xxxxxx, X10XX04 xxxxxxx xxxxxx, X10XX05 xxxxxxx xxxxxx, | ||
8/3 | xxxxxx k terapii xxxxxxx, xxxxxxxx a xxxxxxx xxxxxx xxxxxxxx, xxxxxx. | X10XX04 xxxxxxx xxxxxxx, X10XX05 insulin xxxxxxx | ||
9 | Xxxxxx x xxxxxxx diabetu | 9/1 | xxxxxx x xxxxxxx xxxxxxx, deriváty xxxxxxxxxxxx - I. x II. xxxxxxxx, x.x. (xxxxx glipizidu, xxxxxxxxxx x xxxxxxxxxxx) | X10XX01 xxxxxxxxxxxx, X10XX03 xxxxxxxxxx, |
9/2 | xxxxxx x xxxxxxx xxxxxxx, xxxxxxxx xxxxxxxxxxxx - X. xxxxxxxx, x.x. | X10XX07 xxxxxxxx, X10XX09 xxxxxxxxx, X10XX12 glimepirid | ||
9/3 | xxxxxx x xxxxxxx xxxxxxx, xxxxxxxxx, p.o. | A10BG02 xxxxxxxxxxxx, A10BG03 xxxxxxxxxxx | ||
9/4 | xxxxxx k xxxxxxx xxxxxxx, xxxxxxx, p.o. | X10XX02 xxxxxxxxxx, A10BX03 xxxxxxxxxx | ||
9/5 | xxxxxx k xxxxxxx xxxxxxx, léčiva xxxxxxxxxxx xxxxxxxxxxx xxxxxx | X10XX01 xxxxxxxxxxx, A10BH02 xxxxxxxxxxxx, X10XX04 exenatid, X10XX07 xxxxxxxxxx | ||
10 | Xxxxxx k terapii xxxxxxxx xxxxxxxx | 10/1 | xxxxxx x xxxxxxx xxxxxxxx xxxxxxxx, xxxx xxxxxxx, p.o. | X12XX04 xxxxxxxxx xxxxxxxx, X12XX07 xxxxxxx vápenatý |
10/2 | léčiva x xxxxxxx deficitu xxxxxxxx, xxxx xxxxxxx, x.x. | X12XX06 mléčnan xxxxxxxxx, A12CC09 xxxxxx xxxxxxxxx | ||
11 | Enzymy x xxxxxxxxxx xxxxxxxxxxx xxxxxxx dědičných xxxxxx xxxxxxxxxx xxxxxxxxxxx | 11/1 | xxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxx dědičných xxxxxx lipidového xxxxxxxxxxx, xxxxxx. | X16XX03 agalsidáza xxxx, X16XX04 xxxxxxxxxx xxxx |
12 | Xxxxxx x xxxxxxx xxxx x xxxxxxxxx tromboembolických xxxxxxxxxx | 12/1 | léčiva x terapii nebo x xxxxxxxxx tromboembolických xxxxxxxxxx, xxxxxxxxxxxxxxxx xxxxxxxx, xxxxx síly určené xxxxxxxxx x xxxxxxxxx XXX, xxxxxx. | B01AB04 xxxxxxxxxx, B01AB05 xxxxxxxxxx, X01XX06 nadroparin, X01XX08 xxxxxxxxx, B01AB12 xxxxxxxxx |
12/2 | xxxxxx x xxxxxxx xxxx k xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, nízkomolekulární xxxxxxxx, vyšší xxxx xxxxxx především k xxxxxxx XXX, parent. | X01XX04 dalteparin, X01XX05 xxxxxxxxxx, B01AB06 xxxxxxxxxx, X01XX08 reviparin, X01XX12 xxxxxxxxx | ||
12/3 | léčiva x xxxxxxx nebo k xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxxxx xxxxxxx Xx x trombinu, xxxxxx. | X01XX01 xxxxxxxxx, X01XX02 lepirudin, B01AE06 xxxxxxxxxxx | ||
13 | Léčiva x xxxxxxx nebo x profylaxi tromboembolických xxxxxxxxxx | 13/1 | léčiva x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, antagonisté xxxxx XXX xx receptor, x.x. | X01XX04 xxxxxxxxxxx, X01XX05 tiklopidin, |
13/2 | xxxxxx x xxxxxxx nebo x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, přímé xxxxxxxxxx xxxxxxx Xx x xxxxxxxx, p.o. | X01XX07 xxxxxxxxxx, X01X xxxxxxxxxxx, X01X xxxxxxxx | ||
14 | Xxxxxxxxxx xxxxxx x xxxxxxx plicní xxxxxxxxxx xxxxxxxxxx (XXX) | 14/1 | xxxxxxxxxx xxxxxx x xxxxxxx xxxxxx arteriální xxxxxxxxxx (PAH), xxxxxx. x inhal. aplikace | X01XX09 epoprostenol, B01AC11 xxxxxxxx, B01AC21 xxxxxxxxxxxx |
14/2 | xxxxxxxxxx léčiva x xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx (XXX), p.o. | X02XX01 xxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxx, X02X xxxxxxxxxx | ||
15 | Xxxxxxxxxxxxx, parent. | 15/1 | xxxxxxxxxxxxx, xxxxxx, xxxxxx. | X01XX02 altepláza, X01XX04 xxxxxxxxx, X01XX11 xxxxxxxxxxxx |
16 | Xxxxxxxxxxxxxxxxx - xxxxxxxxxxxxx | 16/1 | xxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, p.o. | X02XX02 xxxxxxxx tranexámová, B02AA03 xxxxxxxx xxxxxxxxxxxxxxxxxxx |
16/2 | antifibrinolytika, xxxxxxxxxxxxx, xxxxxx. | X02XX02 xxxxxxxx tranexámová, X02XX03 xxxxxxxx xxxxxxxxxxxxxxxxxxx | ||
17 | Xxxxxx x xxxxxxx xxxxxx - xxxx xxxxxx | 17/1 | xxxxxx x xxxxxxx anémií, xxxxxxxxx xxxx trojmocné xxxxxx, p.o. | X03XX02 xxxxxxx xxxxxxxxx, X03XX07 xxxxx xxxxxxxxx, X03XX02 xxxxxxx xxxxxx x xxxxxxxxxxx |
17/2 | xxxxxx x xxxxxxx xxxxxx, xxxxxxxxx xxxxxx, xxxxxx. | X03XX02 xxxxxxx xxxxxx x xxxxxxxxxxx, X03XX07 glukonan xxxxx-xxxxxxxx | ||
18 | Xxxxxxx xxxxxxxxxxx xxxxxxxxxxx působením xx receptor erythropoetinu | 18/1 | xxxxxxx xxxxxxxxxxx xxxxxxxxxxx, xxxxxx. | X03XX01 xxxxxxxxxxxxx (xxxxxxx xxxx), X03XX02 darbepoetin alfa, X03XX03 pegepoetin (Xxxxxx-xxxxxxxxxxxxxxxx- xxxxxxx beta), xxxxxxx xxxx, epoetin delta, xxxxxxx zeta |
20 | Xxxxxxxx NO k xxxxxxx xxxxxx xxxxxxxx | 20/1 | xxxxxxxx XX x xxxxxxx xxxxxx xxxxxxxx - xxxxxxx xxxxxxxx záchvatu, xxxxxxx. | X01XX02 glycerol xxxxxxxxx, X01XX08 xxxxxxxxx dinitrát |
20/2 | xxxxxxxx XX x xxxxxxx anginy xxxxxxxx - xxxxxxx dlouhodobá, x.x. | X01XX02 xxxxxxxx xxxxxxxxx, X01XX08 isosorbid xxxxxxxx, X01XX14 xxxxxxxxx xxxxxxxxxx, X01XX12 xxxxxxxxxx | ||
20/3 | xxxxxxxx XX x xxxxxxx xxxxxx xxxxxxxx, xxxxxx. | X01XX02 xxxxxxxx xxxxxxxxx, C01DA08 xxxxxxxxx xxxxxxxx | ||
21 | Xxxxxxxxxxxxxxxx | 21/1 | xxxxxxxxxxxxxx látky xxxxxxxx centrálně x xxxxxxxxx, x.x. (xxxxx xxxxxxxxx) | C02AB01 methyldopa, X02XX05 xxxxxxxxx, C02AC06 xxxxxxxxxx, X02XX06 xxxxxxxx |
22 | Diuretika | 22/1 | xxxxxxxxx, x.x. | X03XX03 xxxxxxxxxxxxxxxxxx, X03XX04 xxxxxxxxxxxx, X03XX11 xxxxxxxxx, X03XX xxxxxxxxx |
23 | Xxxxxxxxxxxxxxxx - beta-blokátory | 23/1 | xxxxxxxxxxxxxxxx, betablokátory xxxxxxxxxxxxxxxx xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxx, x.x. | C07AA17 xxxxxxxxxx, C07AB02 metoprolol (xxxxxxxxxxxxx lékové xxxxx), X07XX03 atenolol, |
23/2 | xxxxxxxxxxxxxxxx, xxxxxxxxxxxxx kardioselektivní xxxxxxxxxxx x dlouhodobě xxxxxxxx, x.x. | X07XX02 metoprolol (xxxxxxxxxxx xxxxxx formy), X07XX04 xxxxxxxx, C07AB05 xxxxxxxxx, C07AB07 xxxxxxxxxx, X07XX08 xxxxxxxxxx, X07XX12 xxxxxxxxx, X07XX02 karvedilol | ||
24 | Xxxxxxxxxxxxxxxx - xxxxxxxxx xxxxxxxxxx xxxxxx | 24/1 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx kanálů xxxxxxxxxxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxxx, x.x. | C08CA01 xxxxxxxxx, X08XX02 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX03 xxxxxxxxx (xxxxxxxxxxx lékové xxxxx), X08XX08 xxxxxxxxxxx, X08XX09 xxxxxxxxx, X08XX10 xxxxxxxxxx, C08CA12 barnidipin, X08XX13 lercanidipin |
24/2 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx xxxx xxxxxxxxxx x střednědobé xxxxxxxx, x.x. | C08CA02 felodipin (xxxxxxxxxxxxx xxxxxx xxxxx), X08XX03 isradipin (neretardované xxxxxx xxxxx), X08XX05 xxxxxxxxx (xxxxxxx lékové xxxxx) | ||
24/3 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx kanálů xxxxxxxxxxxxxxxxxxx x benzothiazepinového xxxx, x.x. | X08XX01 xxxxxxxxx, X08XX01 diltiazem | ||
25 | Xxxxxxxxxxxxxxxx - xxxxxx xxxxxxxx na xxxxxx xxxxx- xxxxxxxxxxx-xxxxxxxxxx | 25/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX xxxxxxxxxx a xxxxxxxxxxx xxxxxxxx, x.x | X09XX01 xxxxxxxxx, C09AA02 enalapril, X09XX06 quinapril |
25/2 | antihypertenziva, xxxxxxxxxx XXX dlouhodobě xxxxxxxx, x.x. | X09XX03 xxxxxxxxxx, X09XX04 xxxxxxxxxxx, X09XX05 ramipril, X09XX08 xxxxxxxxxx, X09XX09 xxxxxxxxxx, X09XX10 xxxxxxx xxxxx, X09XX11 spirapril, X09XX13 xxxxxxxxx, C09AA16 xxxxxxxxx | ||
25/3 | xxxxxxxxxxxxxxxx, antagonisté xxxxxxxxxxxx XX xxxxxxx, x.x. | X09XX01 xxxxxxxx, X09XX02 xxxxxxxxxx, C09CA03 xxxxxxxxx, X09XX04 xxxxxxxxxx, X09XX06 xxxxxxxxxxx, C09CA07 xxxxxxxxxxx, X09XX08 xxxxxxxxxx | ||
25/4 | xxxxxxxxxxxxxxxx, xxxxxxxxxxx aldosteronu, x.x. | X03XX01 spironolakton, X03XX04 xxxxxxxxx | ||
26 | Xxxxxxxxx xxxxxxxxxxxxxx | 26/1 | xxxxxxxxx xxxxxxxxxxxxxx, x.x. (kromě xxxxxxxxxxxxxxx námelových xxxxxxxxx x xxxxxxxxx xxxxxxxxxxxxxxxxxxx) | X04XX02 xantinol nikotinát, X04XX03 xxxxxxxxxxxx, X04XX02 xxxxxxxxxx, C04AX21 naftidrofuryl, X04XX04 xxxxxxxxx xxxxxxxxx |
26/2 | xxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. | X04XX02 tolazolin, X04XX03 xxxxxxxxxxxx, C04AD xxxxxxxx | ||
27 | Venofarmaka | 27/1 | xxxxxxxxxxx, p.o. | X05XX01 xxxxxxxxx vápenatý, X05XX04 xxxxxxxxxx, X05XX53 diosmin xxxxxxxxx X05XX01 xxxxxxxxxx, X05XX xxxxx |
28 | Xxxxxxxxxxxxxx | 28/1 | hypolipidemika, xxxxxxx, x.x. | X10XX01 xxxxxxxxxxx, X10XX02 lovastatin, X10XX03 xxxxxxxxxxx, C10AA04 xxxxxxxxxxx, X10XX05 xxxxxxxxxxxx, X10XX07 xxxxxxxxxxxx |
28/2 | xxxxxxxxxxxxxx, xxxxxxx, p.o. | X10XX02 xxxxxxxxxx, X10XX05 xxxxxxxxxx, X10XX08 xxxxxxxxxxx | ||
29 | Xxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx | 29/1 | xxxxxxxxxxxx xxxxxxxxx v dermatologii x xxxxxxx terapii, (xxxxx xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx x tridecanamini undecylenas) | X01XX01 xxxxxxxx, D01AA02 xxxxxxxx, D01AC01 klotrimazol, X01XX03 ekonazol, X01XX08 xxxxxxxxxxx, X0x XX10 xxxxxxxxx, X01XX11 xxxxxxxxxx, X01XX16 flutrimazol, X01XX14 xxxxxxxxxx, D01AE15 xxxxxxxxxx, X01XX22 naftifin |
29/2 | xxxxxxxxxxxx xxxxxxxxx x dermatologii x lokální xxxxxxx, xxxxxxx | X01XX04 xxxxxxxx xxxxxxxxxxxx, X01XX xxxx xxxxxxxxxxxx k xxxxxxx xxxxxxx | ||
30 | Antipsoriatika xxxxxxxxx x dermatologii | 30/1 | antipsoriatika xxxxxxxxx x xxxxxxxxxxxx x xxxxxxx xxxxxxx, xxxxx | X05XX dehty, X05XX xxxxx (odbarvený xxxxx) |
30/2 | xxxxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx x lokální xxxxxxx, xxxx léčiva xxx dehty | X05XX02 xxxxxxxxxxxx, X05XX03 xxxxxxxxxx, X05XX04 tacalcitol, X05XX05 xxxxxxxxx | ||
31 | Xxxxxxxxxxx xxxxxxxxx k xxxxxxx xxxxxxx | 31/1 | xxxxxxxxxxx xxxxxxxxx x lokální xxxxxxx | X06XX01 xxxxxxxx xxxxxxxx, X06XX09 xxxxxxxxx |
32 | Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii - xxxxx x středně xxxxx | 32/1 | xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx, xxxxx a xxxxxxx xxxxx 1. x 2. generace | X07XX19 xxxxxxxxxxxx xxxxxx (0,01%), X07XX04 xxxxxxxxxxx xxxxxxxx (0,01%), X07XX02 xxxxxxxxxxxxx acetát (1,0%), X07XX03 xxxxxxxxxxx (0,4%), X07XX09 xxxxxxxxxxxx xxxxxxxx (0,1%) |
32/2 | kortikosteroidy používané x lokální xxxxxxx, xxxxx x xxxxxxx xxxxx 3. x 4. xxxxxxxx | X07XX10 xxxxxxxxxxxxx (0,05%), X07XX08 xxxxxxx, X07XX02 xxxxxxxxxxxxxx xxxxxxx (0,1%) | ||
33 | Xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx terapii xxxxx x xxxxx xxxxx | 33/1 | xxxxxxxxxxxxxxx používané x xxxxxxx xxxxxxx, xxxxx x velmi xxxxx 1. a 2. xxxxxxxx | X07XX04 xxxxxxxxxxx xxxxxxxx (0,05%- 0,2%), X07XX03 xxxxxxxxxxxxxx (0,25%) |
33/2 | xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii, xxxxx x xxxxx xxxxx 3. x 4. xxxxxxxx | D07AC01 xxxxxxxxxxxx xxxxxxx (0,1%), X07XX01 xxxxxxxxxxxx dipropionát (0,05%), D07AC17 xxxxxxxxxx xxxxxxxxx (0,05%), D07AC12 Xxxxxxxxxxx xxxxxxxxx (0,05%), X07XX02 Xxxxxxxxxx (0,1%), X07XX01 klobetasol propionát (0,05%), X07XX14 xxxxxxxxxxxxxxxxx xxxxxxxx (0,1%), X07XX13 xxxxxxxxx xxxxxx (0,1%), X07XX18 xxxxxxxxxxxx | ||
34 | Xxxxxxxxxxx x xxxxxxxxxxxxxx | 34/1 | xxxxxxxxxxx x xxxxxxxxxxxxxx - obsahující xxxxxxxxx dusík | D08AJ xxxxxxxxxx xxxxxxxxxx xxxxxxxxx xxxxx |
35 | Xxxxxx xxxxxxxxx k xxxxxxx xxxxxxx acne xxxxxxxx | 35/1 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx xxxxxxxx, xxxxxxxxx | X10XX01 xxxxxxxxx, D10AD03 xxxxxxxx, X10XX04 xxxxxxxxxxxx |
35/2 | xxxxxx xxxxxxxxx x xxxxxxx terapii xxxx xxxxxxxx, xxxxxxx léčiva | X10XX01 benzoyl peroxid, X10XX03 xxxxxxxx azelaová | ||
35/3 | xxxxxx používaná x xxxxxxx xxxxxxx xxxxxxxxxxxx, xxxxxxxxxxxx látky | X10XX01 xxxxxxxxxxx, D10AF02 xxxxxxxxxxxx | ||
36 | Imimomodulancia používaná x xxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx | 36/1 | xxxxxxxxxxxxxxx používaná x xxxxxxx xxxxxxx atopické xxxxxxxxxxx | D11AX14 xxxxxxxxxx, X11XX15 pimelcrolimus |
37 | Xxxxxxxxxxxxx antimykotika | 37/1 | xxxxxxxxxxxxx xxxxxxxxxxxx, lok. xxxx vag. xxxxxxxx | X01XX02 xxxxxxxxxxx, X01XX05 xxxxxxxx, X01XX12 xxxxxxxxxxxx |
38 | Gynekologická antiseptika | 38/1 | xxxxxxxxxxxxx xxxxxxxxxxx, xxx. xxxx xxx. xxxxxxxx, (xxxxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx) | X0XXX03 xxxxxxxxxxxxx, X01XX11 xxxxxxxxx xxx, G01AX xxxxxxxxxxxx xxxxx |
39 | Xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii | 39/1 | xxxxxxxxxxxxx xxxxxxxxxxx, lok. xxxx xxx. xxxxxxxx | X01XX02 xxxxxxxxx, X01XXX0 xxxxxxxxxxx, G01AX12 xxxxxxxxxx |
40 | Xxxxxxxxxxxxxx | 40/1 | xxxxxxxxxxxxxx, xxxxxx. | X02XX01 xxxxxxxxx, G02AD04 karboprost |
41 | Xxxxxxxxxx xxxxxxxxxx | 41/1 | xxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx X. xxxxxxxx, x.x. | X02XX01 xxxxxxxxxxxx, X02XX0X xxxxxxxx |
41/2 | xxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx XX. xxxxxxxx, x.x. | G02CB03 xxxxxxxxxx, X02XX04 xxxxxxxxxx | ||
42 | Xxxxxxxxx | 42/1 | xxxxxxxxx, x.x. | X03XX03 xxxxxxxxx, X03XX04 xxxxxxx, X03XX05 xxxxxxx |
42/2 | xxxxxxxxx, xxxxxxx xxx. xxxxxxxx | X03XX03 xxxxxxxxx, G03CA04 xxxxxxx | ||
43 | Progestiny | 43/1 | xxxxxxxxxx X. xxxxxxxx, x.x. | X03XX02 xxxxxxxxxxxxxxxxxx, X03XX02 norethisteron, X03XX03 xxxxxxxxxxx |
43/2 | xxxxxxxxxx II. xxxxxxxx, p.o. | G03DA04 xxxxxxxxxxx, X03XX01 xxxxxxxxxxxxx | ||
43/3 | xxxxxxxxxx, xxxxxx. | G03DA03 xxxxxxxxxxxxxxxxxx, X03XX04 progesteron (xxxxxxx xxxxxx xxxxx) | ||
44 | Xxxxxxxxxxxxx | 44/1 | xxxxxxxxxxxxx xxxxxxxx, xxxxxx. | X03XX01 choriový gonadotropin, X03XX08 xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxx |
44/2 | xxxxxxxxxxxxx xxxxxxx, xxxxxx. | G03GA02 xxxxxxxxxxxx xxxxxx, gonadotropin xxxxxx xxxxxx xxxxxxx, X03XX04 xxxxxxxxxxxxx, urofolitropin vysoce xxxxxxx, X03XX05 xxxxxxxxxx xxxx, G03GA06 xxxxxxxxxx xxxx, X03XX07 xxxxxxxx xxxx | ||
45 | Močová xxxxxxxxxxxx | 45/1 | močová xxxxxxxxxxxx, xxxxxxxxxxxxx xxxxx, x.x. a xxxxxxxxx. xxxxxxxx | G04BD04 xxxxxxxxxx, X04XX06 propiverin, X04XX07 xxxxxxxxxx, X06XX09 xxxxxxxx xxxxxxx |
45/2 | xxxxxx xxxxxxxxxxxx, xxxxxxxxxxx xxxxx, x.x. | X04XX07 xxxxxxxxxx, X04XX08 xxxxxxxxxxx, X04XX10 xxxxxxxxxxx, X04XX11 xxxxxxxxxxx | ||
46 | Xxxxxx k xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxx | 46/1 | xxxxxx x xxxxxxx benigní hyperplazie xxxxxxxx, xxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxxxxx, p.o. | X02XX04 xxxxxxxxx, X04XX01 xxxxxxxxx, X04XX02 tamsulosin, X04XX03 terazosin |
46/2 | léčiva x xxxxxxx benigní xxxxxxxxxxx xxxxxxxx, xxxxxxx, x. x. | G04CB01 xxxxxxxxxx, X04XX03 mepartricin | ||
47 | Xxxxxxxxxxx růstového xxxxxxx | 47/1 | xxxxxxxxxxx xxxxxxxxx hormonu, krátkodobě xxxxxxxx, xxxxxx. | X01XX01 xxxxxxxxxxxx, X01XX02 xxxxxxxxx |
47/2 | xxxxxxxxxxx ristového hormonu - xxxxxxxxxx působící, xxxxxx. | H01CB02 oktreotid, X01XX03 lanreotid | ||
48 | Xxxxxxxxxxx gonadotropin xxxxxxxxxxxx xxxxxxx | 48/1 | xxxxxxxxxxx xxxxxxxxxxxx - uvolňujícího xxxxxxx, xxxxxx. | X01XX01 xxxxxxxxx, H010002 cetrorelix |
49 | Xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxx | 49/1 | xxxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx, x.x. | X02XX04 methylprednisolon, X02XX07 xxxxxxxxx, X02XX08 xxxxxxxxxxxxx |
49/2 | xxxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxxxxxxx účinkem, xxxxxx. - depotní | H02AB01 xxxxxxxxxxxx (depotní xxxxxx xxxxx), X02XX04 methylprednisolon (xxxxxxx xxxxxx xxxxx) | ||
50 | Xxxxxxxxxxxxxxx xxxxxx | 50/1 | xxxxxxxxxxxxxxx xxxxxx, x.x. | X03XX02 xxxxxxxxxxxxxxxx, X03XX01 xxxxxxxxxx, X03XX02 xxxxxxxxxx |
51 | Tetracykliny | 51 /1 | xxxxxxxxxxxx, x.x. | J01AA02 xxxxxxxxxx, X01XX08 xxxxxxxxxx |
52 | Xxxxxxxxxx s xxxxx xxxxxxxx xxxxxx | 52/1 | xxxxxxxxxx x xxxxx xxxxxxxx, p.o. | X01XX02 xxxxxxxxxxxxxxxxxxxxx, X01XX06 xxxxxxxxxxx, X01XX10 benzatbin xxxxxxxxxxxxxxxxxxxxx |
53 | Cefalosporiny | 53/1 | xxxxxxxxxxxxx I. generace, x.x. | X01XX01 cefalexin, X01XX05 xxxxxxxxxx, J01DC04 xxxxxxxx, |
53/2 | xxxxxxxxxxxxx XX. xxxxxxxx, x.x. | J01DC02 xxxxxxxxx axetil, J01DC10 xxxxxxxxx | ||
53/3 | xxxxxxxxxxxxx X. xxxxxxxx, xxxxxx. | J01DB03 xxxxxxxxx, X01XX04 cefazolin | ||
53/4 | xxxxxxxxxxxxx XXX. xxxxxxxx, xxxxxx. (xxxxx xxxxxxxxxxxx) | X01XX01 xxxxxxxxx, J01DD02 xxxxxxxxxx, X01XX04 xxxxxxxxxx | ||
54 | Xxxxxxxxxxx | 54/1 | xxxxxxxxxxx, xxxxxx. | X01XX02 xxxxxxxxx, J01DH03 xxxxxxxxx |
55 | Xxxxxxxxxxx, azalidová, xxxxxxxxxx x xxxxxxxxxxxxx xxxxxxxxxxx | 55/1 | xxxxxxxxx, x.x. | X01XX01 erythromycin, X01XX02 spiramycin, J01FA06 xxxxxxxxxxxxx, J01FA09 xxxxxxxxxxxxxx, X01XX10 xxxxxxxxxxxx |
55/2 | linkosamidy, x.x. | J01FF01 xxxxxxxxxxx, X01XX02 xxxxxxxxxx | ||
56 | Xxxxxxxxx | 56/1 | xxxxxxxxx, x.x. (xxxxx moxifloxacinu) | X01XX01 xxxxxxxxx, J01MA02 xxxxxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX06 norfloxacin, X01XX12 xxxxxxxxxxxx |
57 | Imidazolové xxxxxxxx | 57/1 | xxxxxxxxxxx xxxxxxxx, p.o. | J01XD01 xxxxxxxxxxxx, X01XX03 omidazol |
58 | Xxxxxxxxxxxx k xxxxxxxxx terapii | 58/1 | xxxxxxxxxxxx x xxxxxxxxx xxxxxxx, triazolové deriváty, x.x. | J02AC03 xxxxxxxxxxx, X02XX04 xxxxxxxxxxx |
59 | Xxxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxx vyvolaným xxxxxxxxxxx xxxxxxx | 59/1 | xxxxxxxxx xxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxx xxxxxx xxxxx hominis, x.x. | X05XX01 xxxxxxxxx, X05XX09 xxxxxxxxxxx, X05XX11 xxxxxxxxxxxx, X05XX15 brivudin |
60 | Xxxxxxxxxxxxxxxxx | 60/1 | xxxxxxxxxxxxxxxxx xxxxxxxxxxxx a xxxxxxxxxxxx xxxxxxxxxx reverzní xxxxxxxxxxxx, xxxxx xxx XXX xxxxxxx, x.x. | X05XX02 xxxxxxxxx, X05XX04 stavudin, X05XX06 xxxxxxxx, X05XX09 xxxxxxxxxxxx |
60/2 | antiretrovirotika xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx, xxxxx xxx XXX xxxxxxx, x.x. | X05XX08 xxxxxxxx, X05XX10 entecavir | ||
61 | Xxxxxxxxxx xxxxxxxxxxxxxx | 61/1 | xxxxxxxxxx xxxxxxxxxxxxx, p. x. a xxxxx. xxxxxxxx | X05XX01 xxxxxxxxx, X05XX02 oseltamivir |
62 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx | 62/1 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx, x.x. | J06BA01 xxxxxxxxxxxxxx normální xxxxxx xxx intramuskulární xxxxxxxx |
62/2 | xxxxxxxxxxxxxx xxxxxxxx xxxxxx, x.x. | X06XX01 imunoglobuliny xxxxxxxx xxxxxx xxx xxxxxxxxxx aplikaci | ||
62/3 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx, xx. | X06XX02 xxxxxxxxxxxxxx normální xxxxxx xxx intravenózní xxxxxxxx | ||
63 | Xxxxxx | 63/1 | xxxxxx, xxxxxx. | X01XX01 xxxxxxxxxx, X01XX02 xxxxxxxxx |
64 | Xxxxxxxxxx xxxxxxxxxxxxx | 64/1 | inhibitory xxxxxxxxxxxxx, x.x. | X01XX04 xxxxxxxxx, L01XE05 sorafenib |
65 | Xxxxxxxxxxxx xxxxxxx xxxxxxxxxxxx-xxxxxxxxx xxxxxxx | 65/1 | xxxxxxxxxxxx xxxxxxx gonadotropin-releasing xxxxxxx, xxxxxx. | L02AE02 xxxxxxxxxxx, L02AE03 xxxxxxxxx, X02XX04 triptorelin |
66 | Xxxxxxxxxxxxx a inhibitory xxxxxxxx | 66/1 | xxxxxxxxxxxxx, x.x. | X02XX01 tamoxifen, X02XX02 xxxxxxxxx |
66/2 | inhibitory xxxxxxxx, x.x. | L02BG03 xxxxxxxxxx, X02XX04 xxxxxxxx, X02XX06 exemestan | ||
67 | Xxxxxxxxxxxxx | 67/1 | xxxxxxxxxxxxx, x.x. | X02XX01 xxxxxxxx, X02XX03 bikalutamid |
69 | Xxxxxxxxxxx x xxxx xxxxxx | 69/1 | xxxxxxxxxxx xxxx xxxxxx x xxxxxxx vybraných onkologických xxxxxxxxxx, - xxxxxxxxxxxx xxxxx, xxxxxx. | X03XX01 xxxxxxxxxx xxxx xxxxxxx, X03XX04 xxxxxxxxxx xxxx-2x, X03XX05 xxxxxxxxxx xxxx-2x |
69/2 | xxxxxxxxxxx alfa-2 - xxxxxxxxxx xxxxx, xxxxxx. | X03XX11 xxxxxxxxxxxxx xxxx-2x, X03XX10 xxxxxxxxxxxxx xxxx-2x | ||
69/3 | xxxxxxxxxxx a xxxxxxx xxxxxx x terapii xxxxxxxxxxx xxxxxxxx, xxxxxx. | X03XX07 xxxxxxxxxx beta-1a, X03XX08 xxxxxxxxxx xxxx-1x, X03XX13 glatiramer xxxxxx, | ||
70 | Xxxxxxxxxxxxxx | 70/1 | xxxxxxxxxxxxxx- xxxxxxxxxx, x.x. x parent. (kromě xxxxxxxxxxx x xxxxxxxxxxxx) | X04XX02 xxxxxxxxxx, L04AA06 xxxxxxxx xxxxxxxxxxxxx, X04XX10 xxxxxxxxx, X04XX18 everolimus |
70/2 | xxxxxxxxxxxxxx - xxxxxxxxxx, xxxxxx x xxxxxxx xxxxxxxxxxxx, xxxxxxx xxxx xxxxxxxxx onemocnění, parent. | X04XX01 xxxxxxxxxx, X04XX02 xxxxxxxxxx, X04XX04 adalimumab, X04XX21 efaliziunab, X04XX24 xxxxxxxxx | ||
71 | Xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx | 71/1 | xxxxxxxxxxx xxxxxxxxxxxxxx léčiva - xxxxxxxxxxxx, p.o. | X01XX05 diklofenak, X01XX01 xxxxxxxxx, M01AC05 xxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX01 xxxxxxxxx, M01AE02 naproxen, X01XX03 ketoprofen, X01XX11 xxxxxxxx tiaprofenová, X01XX12 xxxxxxxxx, M01AE17 dexketoprofen, X01XX02 kyselina xxxxxxxxxxx, X01XX01 xxxxxxxxx, M01AX17 xxxxxxxxx |
71/2 | xxxxxxxxxxx xxxxxxxxxxxxxx, xxxx. xxxxxxxx | X01XX01 xxxxxxxxxxx, X01XX05 diklofenak, X01XX06 meloxikam, X01XX01 xxxxxxxxx, X01XX03 xxxxxxxxxx | ||
71/3 | xxxxxxxxxxx antiflogistika, xxxxxx. | X01XX05 xxxxxxxxxx, M01AC01 xxxxxxxxx, X01XX06 xxxxxxxxx, X01XX03 ketoprofen, X01XX04 xxxxxxxxx | ||
71/4 | nesteroidní xxxxxxxxxxxxxx xxxxxx COX 2 xxxxxxxxxx (xxxxxx), p.o. | X01XX01 xxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX05 xxxxxxxxxx | ||
73 | Xxxxxxxxx působící xxxxxxxxxxxxx | 73/1 | xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx, p.o. | X03XX01 xxxxxxxx, X03XX02 xxxxxxxxx, X03XX04 xxxxxxxxxx, X03XX05 xxxxxxxxxxxxxxx, X03XX07 xxxxxxxxxx, X05XX01 xxxxxxxxxxx |
73/2 | xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx, xxxxxx. | M03BX04 xxxxxxxxxx, X03XX05 xxxxxxxxxxxxxxx | ||
74 | Xxxxxx x terapii x xxxxxxxxx osteoporózy | 74/1 | xxxxxx x xxxxxxx a xxxxxxxxx xxxxxxxxxxx, xxxxxxx X, x.x. | A11CC01 ergokalciferol, X11XX05 xxxxxxxxxxxxxxx |
74/2 | xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, metabolity xxxxxxxx D, p.o. | X11XX03 xxxxxxxxxxxx, X11XX04 xxxxxxxxxx | ||
74/3 | xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, bisfosfonáty, p. x. | X05XX04 xxxxxxxx xxxxxxxxxxx, M05BA061kyselina xxxxxxxxxxx, X05XX07 xxxxxxxx risedronová, | ||
74/4 | xxxxxx k terapii x xxxxxxxxx xxxxxxxxxxx, xxxxxxx xxxxxxxxxxx xxxxxxx x analoga, xxxxxx. | X05XX02 xxxxxxxxxxx, H05AA03 xxxxxxxxxxx | ||
75 | Xxxxxx x terapii hyperkalcémie x/xxxx xxxxxxxxx u xxxxxxxxx onemocnění | 75/1 | xxxxxx x xxxxxxx xxxxxxxxxxxxx x/xxxx osteolýzy x xxxxxxxxx xxxxxxxxxx, xxxxxx. | X05XX02 xxxxxxxx xxxxxxxxxx, M05BA03 xxxxxxxx xxxxxxxxxxx, X05XX06 kyselina xxxxxxxxxxx, M05BA08 xxxxxxxx xxxxxxxxxxx |
76 | Xxxxxxxxxx xxxxxxx | 76/1 | xxxxxxxxxx xxxxxxx, xxxxxx. | N01AH01 xxxxxxxx, X01XX02 xxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX06 xxxxxxxxxxxx |
77 | Anestetika xxxxxxx | 77/1 | xxxxxxxxxx xxxxxxx, xxxxxx. | N01AB02 xxxxxxx, N01BB01 xxxxxxxxxx, X01XX03 xxxxxxxxxx, N01BB09 xxxxxxxxxx, X01XX10 xxxxxxxxxxxxxx, X01XX trirnekain |
78 | Xxxxxxx | 78/1 | xxxxx xxxxxxx, p.o. | X02XX03 xxxxxxxxxxx, N02AA05 oxykodon |
78/2 | xxxxx xxxxxxx, transdenn. xxxxxxxx | N02AB03 xxxxxxxx, X02XX01 xxxxxxxxxxx | ||
78/3 | xxxxx xxxxxxx, x.x. | N02AA08 xxxxxxxxxxxxx, N02AX02 xxxxxxxx | ||
79 | Analgetika-antipyretika | 79/1 | xxxxxxxxxx-xxxxxxxxxxxx, x.x. | N02BA01 xxxxxxxx xxxxxxxxxxxxxxxx, N02BA02 xxxxxxxxx, N02BB02 metarnizol, X02XX01 xxxxxxxxxxxx |
79/2 | xxxxxxxxxx-xxxxxxxxxxxx, xxxxxx. | X02XX02 metamizol X02XX01 paracetarnol | ||
80 | Xxxxxxxxxxxxx x xxxxxxx xxxxxxxx záchvatu | 80/1 | xxxxxxxxxxxxx k terapii xxxxxxxx záchvatu, xxxxxxxxxx xxxxxxxx xxxxxxxxxx, p.o. | X02XX01 xxxxxxxxxxx, N02CC02 xxxxxxxxxxx, N02CC03 xxxxxxxxxxxx, X02XX06 eletriptan, X02XX07 xxxxxxxxxxxx |
80/2 | xxxxxxxxxxxxx x xxxxxxx xxxxxxxx xxxxxxxx, xxxxxxxxxx xxxxxxxx xxxxxxxxxx, xxxxx. xxxxxxxx | N02CC01 xxxxxxxxxxx, N02CC03 xxxxxxxxxxxx | ||
81 | Xxxxxxxxxxxxxx jiná | 81/1 | antiepileptika xxxx, x.x. | X03XX12 xxxxxxxxxx, X03XX16 xxxxxxxxxx |
82 | Xxxxxxxxxxxxxxxx | 82/1 | antiparkinsonika, xxxxxxxxxxxxxxxx, x.x. | X04XX02 xxxxxxxxx, X04XX04 procyklidin, X04XX01 xxxxxxxxxxx |
82/2 | xxxxxxxxxxxxxxxx, xxxxxxxx xxxxxxxxx, x.x. | X04XX04 ropinirol, X04XX05 xxxxxxxxxxx | ||
82/3 | xxxxxxxxxxxxxxxx, xxxxxxxxxx XXXX, p.o. | N04BX01 xxxxxxxx, X04XX02 xxxxxxxxx | ||
82/4 | xxxxxxxxxxxxxxxx, xxxxxxxxxx MAO, x. x. | X04XX01 xxxxxxxxx, N04BD02 xxxxxxxxx | ||
83 | Xxxxxxxxxxxxxx xxxxxxxxxxxx | 83/1 | antipsychotika, xxxxxxxxxxxx xxxxxxxx - X. xxxxx, x. o. | X05XX01 xxxxxxxxxxxxx N05AF03 xxxxxxxxxxxxxx, N05AF05 xxxxxxxxxxxxx |
83/2 | xxxxxxxxxxxxxx, - xxxxxxxxxxxx xxxxxxxx II. třídy, x.x. | N05AD01 xxxxxxxxxxx, X05XX01 flupentixol | ||
83/3 | xxxxxxxxxxxxxx, xxxxxxxxxxxx, parent. - xxxxxxxxx | N05AA01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxxxxxxx, X05XX01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/4 | xxxxxxxxxxxxxx, xxxxxxxxxxxx - X. xxxxx, xxxxxx. - xxxxxxx | N05AB02 xxxxxxxxxx, N05AF oxyprothepin | ||
83/5 | xxxxxxxxxxxxxx, xxxxxxxxxxxx - xX. xxxxx, xxxxxx. - xxxxxxx | X05XX01 xxxxxxxxxxx, X05XX01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/6 | antipsychotika x xxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxx, p.o. | N05AD03 xxxxxxxx, X05XX03 xxxxxxx | ||
84 | Antipsychotika - XX. xxxxxxxx | 84/1 | xxxxxxxxxxxxxx druhé volby xxx xxxxxxx risperidonu, x.x. | X05XX03 xxxxxxxxx, X05XX04 quetiapin, X05XX05 xxxxxxxxxx, X05XX11 xxxxxxx |
84/2 | xxxxxxxxxxxxxx xxxxx xxxxx - speciální, x.x. | X05XX04 ziprasidon, X05XX03 xxxxxxxxx, X05XX12 xxxxxxxxxxx | ||
84/3 | xxxxxxxxxxxxxx xxxxxxxxx, xxxxxx. - xxxxxxxxx | X05XX04 xxxxxxxxxx, N05AH03 xxxxxxxxx | ||
85 | Xxxxxxxxxxx | 85/1 | xxxxxxxxxxx, xxxxxxxxxxxxxx, p.o. | X05XX01 diazepam, X05XX02 xxxxxxxxxxxxxxx, X05XX03 xxxxxxxxx, X05XX04 xxxxxxxx, N05BA08 xxxxxxxxxx, N05BA09 xxxxxxxx, X05XX12 alprazolam, X05XX23 xxxxxxxxx |
86 | Xxxxxxxxxxxxx | 86/x | xxxxxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx reuptake xxxxxxxxx, x.x. | X06XX02 xxxxxxxxx, X06XX04 xxxxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, N06AA16 xxxxxxxxx, X06XX21 maprotilin, N06AX03 xxxxxxxxx |
86/2 | xxxxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxx monoaminů xxxxxxxx xxxxxxx transmiterový xxxxxx (SSRI, XXXX, XXXX); xxxxxxxxxxxx inhibitory xxxxxxxxxxxxxxxx (XXXX); xxxxxxxxx xxxxxxxx serotoninu (XXX), x. o. | X06XX03 xxxxxxxxx, X06XX04 xxxxxxxxxx, X06XX05 xxxxxxxxx, X06XX06 xxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 escitalopram, X06XX05 xxxxxxxx, X06XX14 tianeptin | ||
86/3 | xxxxxxxxxxxxx, xxxxxxxxxx inhibitory xxxxxxxx xxxxxxxxx xxxxxxxx xx xxx transmiterové xxxxxxx (XXXX, XxXXX, XXXX), x.x. | N06AX11 xxxxxxxxxx, N06AX16 xxxxxxxxxx, X06XX17 xxxxxxxxxxx, X06XX xxxxxxxxx | ||
87 | Léčiva x xxxxxxx xxxxxxx Xxxxxxxxxxxx xxxx | 87/1 | xxxxxx x xxxxxxx Xxxxxxxxxxxx xxxxxxx, p.o. x transderm. xxxxxxxx | X06XX02 xxxxxxxxx, N06DA03 xxxxxxxxxxx, N06DA04 xxxxxxxxxx, X06XX01 memantin |
88 | Xxxxxxxxxx | 88/1 | xxxxxxxxxx, x.x. | N06BX02 xxxxxxxxx, X06XX03 xxxxxxxxxx, N06BX18 xxxxxxxxxx, N06DX02 xxxxxxxx x Xxxxxx xxxxxx |
88/2 | xxxxxxxxxx, xxxxxx. | X06XX03 xxxxxxxxx, N06BX18 xxxxxxxxxx | ||
89 | Xxxxxxxxxxxxxxxxxxx | 89/1 | xxxxxxxxxxxxxxxxxxx, p.o. (xxxxx xxxxxxxxxx) | X07XX01 xxxxxxxxxx, X07XX02 pyridostigmin, X07XX30 xxxxxxxxxx |
90 | Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx x x xxxxxxxxx xxxxxxxxx xxxxxxxxx | 90/1 | léčiva xxxxxxxxx x xxxxxxx terapii x x xxxxxxxxx xxxxxxxxx rhinitidy, kortikosteroidy, xxxxxxxxxx. aplikace | X01XX01 xxxxxxxxxxxx, X01XX05 budesonid, X01XX06 xxxxxxxxx, X01XX08 xxxxxxxxxx |
90/2 | léčiva xxxxxxxxx x xxxxxxx xxxxxxx x x xxxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxx. aplikace | R01AC02 xxxxxxxxxxxx, X01XX03 azelastin | ||
91 | Xxxxxx používaná x úlevové xxxxxxx xxxxxxx | 91/1 | xxxxxx Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, x.x. | X03XX02 salbutamol, X03XX08 xxxxxxxxxx, R03CC13 xxxxxxxxxxx |
91/2 | xxxxxx Léčiva xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, inhal. xxxxxxxx | X03XX02 xxxxxxxxxx, X03XX03 xxxxxxxxxx, X03XX04 xxxxxxxxx x jiná xxxxxxxxxxxxx | ||
92 | Xxxxxxxxxxx xxxxxxxxxxxxx - xxxxxxxxxxxxxxx | 92/1 | xxxxxxxxxxx antiastmatika, xxxxxxxxxxxxxxx, - ve xxxxx aerosolu, xxxxxxxx x roztoku, xxxxx. xxxxxxxx | X03XX02 budesonid, X03XX05 xxxxxxxxxx, X03XX08 xxxxxxxxxx |
92/2 | preventivní antiastmatika, xxxxxxxxxxxxxxx - prášky, xxxxx xxxxxxxx | X03XX02 xxxxxxxxx, X03XX05 xxxxxxxxxx | ||
93 | Preventivní xxxxxxxxxxxxx | 93/1 | xxxxxxxxxxx xxxxxxxxxxxxx xx skupiny xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx, xxxxx. xxxxxxxx | X03XX12 xxxxxxxxxx, X03XX13 xxxxxxxxxx |
93/2 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxx, x.x. | X03XX04 xxxxxxxx (retardované xxxxxx xxxxx), X03XX05 xxxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx) | ||
93/3 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxxx, p. x. | X03XX01 xxxxxxxxxxx, X03XX03 xxxxxxxxxxx | ||
93/4 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxxx a xxxxxxxxxxxx, xxxxx. xxxxxxxx | X03XX01 xxxxxx xxxxxxxxxx, R03BB04 xxxxxx tiotropia | ||
93/5 | preventivní xxxxxxxxxxxxx, fixní xxxxxxxxx, xxxxx. xxxxxxxx | R03AC12 xxxxxxxxxx/ X03XX05 xxxxxxxxxx, X03XX13 formoterol/ X03XX02 xxxxxxxxx, R03AC13 xxxxxxxxxx/ X03XX01 xxxxxxxxxxxxx | ||
94 | Xxxxxxxxxxxxx | 94/1 | xxxxxxxxxxxxx, x.x. | X05XX01 acetylcystein, X05XX02 bromhexin, X05XX06 xxxxxxxx, R05CB15 xxxxxxxxx |
94/2 | xxxxxxxxxxxxx, xxxxxx. a xxxxx. aplikace | X05XX01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxx, X05XX03 xxxxxxxxxxxx, X05XX05 xxxxx, X05XX06 xxxxxxxx | ||
95 | Antitusika | 95/1 | xxxxxxxxxx, p. o. (xxxxx kodeinu) | X05XX01 xxxxxxxxxxx, R05DA09 xxxxxxxxxxxxxxx, X05XX13 butamirát, X05XX19 xxxxxxxxxxx, R05DB27 xxxxxxxxxxxxxxx |
96 | Antihistaminika | 96/1 | xxxxxxxxxxxxxxx xxxxxxxxx, p.o. | X06XX04 xxxxxxxxx, R06AB03 xxxxxxxxxx, X06XX02 xxxxxxxxxxx, X06XX bisulepin, X06XX02 xxxxxxxxxxxxx, X06XX17 xxxxxxxxx |
96/2 | xxxxxxxxxxxxxxx nesedativní, x.x. | X06XX07 cetirizin, R06AE09 xxxxxxxxxxxxx, X06XX13 xxxxxxxxx, X06XX27 xxxxxxxxxxxx | ||
97 | Xxxxxxxxxxxxx - xxxxxxxxxxxxx | 97/1 | xxxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxx. | X01XX11 xxxxxxxxx, X01XX13 xxxxxxxxxxxxx, X01XX17 lomefloxacin, X01XX19 xxxxxxxxxxxx |
97/2 | xxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx xxxxxxx, xxx. | X01XX01 xxxxxxxxxxxxxx, X01XX11 xxxxxxxxxx, X01XX12 xxxxxxxxxx, X01XX13 xxxxxxx xxxxxxxxx, X01XX24 xxxxxxxxx, S01AB04 xxxxxxxxxxxx | ||
97/3 | oftalmologika, xxxxxxxxxxxxx, xxxxxxxxxxx, lok. | X01XX03 xxxxxxxxx, X01XX09 xxxxxxxxxxx | ||
98 | Oftahmologika - xxxxxxxxxxxxxxx | 98/1 | xxxxxxxxxxxxx, xxxxxxxxxxxxxxx prvé xxxx, xxx. | S01BA01 dexamethason, X01XX02 xxxxxxxxxxxxx |
98/2 | xxxxxxxxxxxxx, xxxxxxxxxxxxxxx druhé xxxx, xxx. | X01XX03 xxxxxxxx, X01XX04 xxxxxxxxxxx, X01XX07 xxxxxxxxxxxxxx | ||
99 | Oftahmologika - xxxxxxxxxxxxxx léčiva | 99/1 | oftalmologika, xxxxxxxxxxxxxx xxxxxx, xxx. | X01XX01 xxxxxxxxxxx, S01BC03 diklofenak |
100 | Xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx | 100/1 | xxxxxxxxxxxxx xxxxxxxxx x terapii glaukomu, xxxxxxxxxxxxxxx nebo xxxxxxxxxxxxxxxxxxx, xxx. | X01XX04 klonidin, X01XX05 brimonidin, X01XX01 xxxxxxxxxx |
100/2 | xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx, xxxxxxxxxx karboanhydrázy, lok. | X01XX03 dorzolamid, X01XX04 xxxxxxxxxxx | ||
100/3 | xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx, xxxxxxxxxxxxx, lok. | X01XX01 xxxxxxx, S01ED02 xxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX05 xxxxxxxxx | ||
100/4 | xxxxxxxxxxxxx xxxxxxxxx x terapii xxxxxxxx, xxxxxxxxxxxxxx xxxx jejich xxxxxxxx, xxx. | X01XX01 xxxxxxxxxxx, S01EE02 imoproston, X01XX03 xxxxxxxxxxx, X01XX04 xxxxxxxxxx | ||
101 | Oftalmologika - xxxxxxxxxx a xxxxxxxxxxxx | 101/1 | oftalmologika, xxxxxxxxxx x xxxxxxxxxxxx, xxx. | X01XX01 atropin, X01XX04 cyklopentolát, X01XX06 xxxxxxxxxx, S01FB01 fenylefrin (xxxxxxxxxxx 10 % xxxx xxxx) |
102 | Xxxxxxxxxxxxx - xxxxxxxxxxxx (xxxxx xxxxxxxxxxxxxxx) | 102/1 | xxxxxxxxxxxxx, xxxxxxxxxxxx - xxxxxxxxxxxxxxx, lok. | S01GA52 xxxxxxxxxx xxxxxxxxxx, X01XX02 xxxxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX07 azelastin, X01XX10 xxxxxxxxx |
102/2 | xxxxxxxxxxxxx, antialergika - xxxxxxxxxxxxx žírných xxxxx, xxx. | X01XX01 xxxxxxxx xxxxxxxxxxxx, S01GX03 xxxxxxxx xxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX08 ketotifen, X01XX09 xxxxxxxxxx | ||
103 | Xxxxxx používaná k xxxxxxx věkem xxxxxxxxx xxxxxxxxx xxxxxxxxxx | 103/1 | xxxxxx x xxxxxxx xxxxx podmíněné xxxxxxxxx xxxxxxxxxx, xxx. | X01XX01 xxxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX04 xxxxxxxxxxx |
104 | Xxxxxxxxxxxx xxxxxxxx xxxxxxxx | 104/1 | terapeutické xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx | X01XX xxxxxxxx xxxxxxxx |
104/2 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/3 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - standardizované xxxxxxxxxx, xxxxxxxxxxxx | V01AA xxxxxxxx xxxxxxxx | ||
104/4 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxx xxxxx | V01AA xxxxxxxx alergenů | ||
104/5 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxx xxxxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/6 | xxxxxxxxxxxx extrakty xxxxxxxx - xxxxxxxxxxxxxxx xxxxxxxx xxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/7 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx, xxxxxxxx xxxxxxx | V01AA xxxxxxxx xxxxxxxx | ||
105 | Xxxxx xxx xxxxxxxxx xxxxxxx | 105/1 | testy xxx xxxxxxxxx xxxxxxx - xxxxxxxxxxxxx | V04CL xxxxx xxx xxxxxxxxx xxxxxxx |
105/2 | testy pro xxxxxxxxx choroby - xxxxx testy | X04XX xxxxx xxx xxxxxxxxx xxxxxxx | ||
106 | Xxxxxx xxxxxxxxx x terapii xxxxxxxxxxxx a xxxxxxxxxxxxxxx | 106/1 | xxxxxx x xxxxxxx xxxxxxxxxxxx a xxxxxxxxxxxxxxx, x.x. | X03XX02 xxxxxxxxx, X03XX03 lanthankarbonát |
107 | Výživy xxx xxxxxxx xxxxxxx xxxxxxxxxxx | 107/1 | xxxxxxxxxx xxxxx xxxxxxxxxxxx bez fenylalaninu (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | V06CA01 |
107/2 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx s xxxxxxx xxxxxxxxx a xxxx xxx děti xx 1 xxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | X06XX02 | ||
107/3 | xxxxxxxxxx směsi aminokyselin xxx fenylalaninu xxx xxxxxxx (xxxxxxxx formy xx xxxxx aminokyselin) | X06XX04 | ||
107/4 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX05 | ||
107/5 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxxx xxxxx xxxxxx xx xxxxx aminokyselin) | X06XX11 | ||
107/6 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxx děti xx 1 roku x poruchou xxxxxxxxxxx xxxxx xxxxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX12 | ||
107/7 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxxxx xxx 1 rok s xxxxxxxx metabolismu cyklu xxxxxxxx (práškové xxxxx xx obsah xxxxxxxxxxxx) | X06XX13 | ||
107/8 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx xx sacharidy x xxxx pro děti xx 1 roku - xxxxxxxxx xxxxxxxxx xxxxxx (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) | X06XX14 | ||
107/9 | xxxxxxxxxx xxxxx xxxxxxxxxxxx bez xxxxxxxxxx, xxxxxxx x xxxxxx xxx xxxx do 1 xxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX14 | ||
107/10 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx pro xxxxxxxx xxx 1 rok (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | V06DD15 | ||
107/11 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, methioninu, xxxxxxxxx x valinu xxx xxxx x xxxxxxxxxxxxxx a xxxxxxxxxxx xxxxxxxx xx 1 xxxx (xxxxxxxx formy xx xxxxx aminokyselin) | X06XX16 | ||
107/12 | xxxxxxxxxx směsi xxxxxxxxxxxx bez xxxxxxxxxx, xxxxxxxxxx, threoninu a xxxxxx pro xxxxxxxx x metylmalonovou x xxxxxxxxxxx acidémií xxx 1 xxx (xxxxxxxx xxxxx na obsah xxxxxxxxxxxx) | X06XX17 | ||
107/13 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxx pro xxxx xx 1 xxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX18 | ||
107/14 | xxxxxxxxxx směsi aminokyselin xxx xxxxxxx pro xxxxxxxx xxx 1 xxx (práškové xxxxx xx xxxxx aminokyselin) | X06XX19 | ||
107/15 | definované xxxxx xxxxxxxxxxxx xxx xxxxxx x se xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx xxxx s xxxxxxxxxx xxxxxxxx do 1 xxxx (práškové xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX20 | ||
107/16 | xxxxxxxxxx směsi xxxxxxxxxxxx bez xxxxxx x xx xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx xxxxxxxx s glatarovou xxxxxxxx nad 1 xxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX21 | ||
107/17 | definované xxxxx xxxxxxxxxxxx bez xxxxxxxxxx xxxxxxxxx L-cystinem xxx xxxx x homocystinurií xx 1 xxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX22 | ||
107/18 | xxxxxxxxxx xxxxx aminokyselin xxx methioninu xxxxxxxxx X-xxxxxxxx xxx pacienty x xxxxxxxxxxxxxx nad 1 xxx (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) | X06XX23 | ||
107/19 | xxxxxxxxxx xxxxx xxxxxxxxxxxx bez xxxxxxxx x fenylalaninu xx xxxxxxxxx a xxxx xxx xxxx xx 1 xxxx - xxxxxxxxx xxxxxxxxx xxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX26 | ||
107/20 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxx xxx xxxx xx 1 xxxx (xxxxxxxx formy xx xxxxx aminokyselin) | X06XX26 | ||
107/21 | definované xxxxx xxxxxxxxxxxx bez tyrosinu x fenylalaninu xxx xxxxxxxx nad 1 xxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | X06XX27 | ||
107/22 | xxxxxxxxxx směsi xxxxxxxxxxxx včetně xxxxxxxxx x xxxxxxx x xxxxxx xxxxxxx xxxxxxxxxxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX29 | ||
108 | Xxxxxx xxxxxxxxx xxxxxx | 108/1 | Xxxxxxxxx xxxxxx xxxxxxxxxx - x tekuté formě | X06XX01 |
108/2 | Xxxxxxxxx xxxxxx xxxxxxxxxx - hyperkalorická | X06XX01 | ||
108/3 | Xxxxxxxxx xxxxxx xxxxxxxxxx - x xxxxxxxx xxxxxxxx isokalorická | X06XX02, X06XX04 | ||
108/4 | Xxxxxxxxx xxxxxx xxxxxxxxxx - x xxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx | V06EB02, V06EB04 | ||
108/5 | Xxxxxxxxx xxxxxx speciální - xxxxxxxxxxxxxx xxx xxxx | X06XX03 | ||
108/6 | Xxxxxxxxx xxxxxx xxxxxxxxx - xxxxxxxxxxxxxx x doplňkem xxxxxxxx anebo xxxxxxxx x xxxxxxxx | X06XX05, X06XX06 | ||
108/7 | Polymerní výživa xxxxxxxxx - xxxxxx xxx xxxxx xxxxxxxxx xxxxxxx | X06XX10 | ||
108/8 | Polymerní xxxxxx speciální - x doplňkem proteinu, xxxxxxxx x xxxxx | X06XX11 | ||
108/9 | Polymerní výživa xxxxxxxxx - s xxxxxxxx xxxxxxxxxxxxxx a xxxxxxxxxxxx | X06XX07, X06XX12, X06XX13, V06EB14, V06EB15, X0XXX16 | ||
108/10 | Xxxxxxxxx xxxxxx xxxxxxxxx - xxxxxxxxxx | X06XX08 | ||
108/11 | Polymerní xxxxxx xxxxxxxxx - x xxxxxxxx XXX xxxxx | X06XX09 | ||
108/12 | Xxxxxxxxxxxxxxx xxxxxx xxxxxx | X06XX01 | ||
108/13 | Xxxxxxxxxxxx | X06XX01 | ||
109 | Výživy - xxxxxxx xxxxx | 109/1 | náhrady xxxxx x xxxxxxx xxxxxxxxx xxxxxxxxx xxxxx | X06XX01 |
109/2 | xxxxxxx xxxxx x xxxxxxx xxxxxxxxxxx hydrolyzátem | X06XX02 | ||
109/3 | xxxxxxx xxxxx x xxxxxx xxxxxxx xxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx | X06XX04 | ||
109/4 | xxxxxxxxx xxxxxxxxx xxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx | V06DE | ||
110 | XXX vodorozpustné nízkoosmolární xxxxxxxxxxx rtg xxxxxxxxxx xxxxx xxxxxxxxx | 110/1 | XXX vodorozpustné xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx jodu 150 xx/xx, xxxxxx. | X08XX09 xxxxxxxxx, X08XX10 xxxxxxxx |
110/2 | XXX xxxxxxxxxxxxx nízkoosmolární xxxxxxxxxxx rtg-kontrastní látky - xxxxxxxxx - xxxxxxxxxxx jodu 200 xx/xx, xxxxxx. | V08AB04 xxxxxxxxxx, X08XX10 xxxxxxxx | ||
110/3 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx rtg-kontrastní xxxxx - xxxxxxxxx - xxxxxxxxxxx jodu 240 xx/xx, xxxxxx. | V08AB02 xxxxxxx, X08XX05 xxxxxxxx, X08XX07 xxxxxxxx | ||
110/4 | RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 300 mg/ml, xxxxxx. | X08XX02 iohexol, X08XX04 iopainidol, V08AB05 xxxxxxxx, X08XX07 xxxxxxxx, X08XX10 xxxxxxxx, X08XX11 xxxxxxxxxx | ||
110/5 | RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 320 xx/xx, xxxxxx. | X08XX03 xxxxxxxx xxxxxxxxxxx, X08XX07 ioversol, X08XX09 xxxxxxxxx | ||
110/6 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - neionické - xxxxxxxxxxx jodu 350 xx/xx, xxxxxx. | X08XX02 xxxxxxx, X08XX07 xxxxxxxx, V08AB10 xxxxxxxx, X08XX11 xxxxxxxxxx | ||
110/7 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 370 mg/ml, xxxxxx. | V08AB04 Xxxxxxxxx, X08XX05 xxxxxxxx | ||
111 | Xxxxxxxxxx látky xxx xxxxxxxxx xxxxxxxxxxx | 111/1 | xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxx, xxxxxx. | X08XX01 mikročástice s xxxxxxxxx, X08XX05 xxxxxx xxxxxxxxxxx |
*) Není-li xxxxxxx x xxxxxxxxx referenční xxxxxxx cesta xxxxxx, xxx do takové xxxxxxxxxx skupiny xxxxxx xxxxxxx x xxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxx xxxxxxxxx x obdobnou xxxx xxxxxxx xxxxxxxxx x xxxxxxxxxxx x xxxxxxxx klinickým xxxxxxxx, xxx xxxxxxx xxxxxx xxxxx podání.
Čl. XX
Xxxx vyhláška xxxxxx xxxxxxxxx xxxxxxxxx xxxx xxx dne xxxxxx xxxxxxxxx.
Ministryně:
Xxxxxxxxx v. r.
Xxxxxxxxx
Xxxxxx předpis x. 114/2009 Sb. xxxxx xxxxxxxxx xxxx 13.5.2009.
Xxxxx jednotlivých xxxxxxxx xxxxx jiných xxxxxxxx předpisů x xxxxxxxx není aktualizováno, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.